Cargando…

Impaired Cross-Modal Inhibition in Alzheimer Disease

BACKGROUND: Successful cognitive performance depends not only on the activation of specific neuronal networks but also on selective suppression of task-irrelevant modalities, i.e., deactivation of non-required cerebral regions. This ability to suppress the activation of specific brain regions has, t...

Descripción completa

Detalles Bibliográficos
Autores principales: Drzezga, Alexander, Grimmer, Timo, Peller, Martin, Wermke, Marc, Siebner, Hartwig, Rauschecker, Josef P, Schwaiger, Markus, Kurz, Alexander
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2005
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1216331/
https://www.ncbi.nlm.nih.gov/pubmed/16159306
http://dx.doi.org/10.1371/journal.pmed.0020288
_version_ 1782124970412867584
author Drzezga, Alexander
Grimmer, Timo
Peller, Martin
Wermke, Marc
Siebner, Hartwig
Rauschecker, Josef P
Schwaiger, Markus
Kurz, Alexander
author_facet Drzezga, Alexander
Grimmer, Timo
Peller, Martin
Wermke, Marc
Siebner, Hartwig
Rauschecker, Josef P
Schwaiger, Markus
Kurz, Alexander
author_sort Drzezga, Alexander
collection PubMed
description BACKGROUND: Successful cognitive performance depends not only on the activation of specific neuronal networks but also on selective suppression of task-irrelevant modalities, i.e., deactivation of non-required cerebral regions. This ability to suppress the activation of specific brain regions has, to our knowledge, never been systematically evaluated in patients with Alzheimer disease (AD). The aim of the current study was to evaluate both cerebral activation and deactivation in (1) healthy volunteers, (2) patients with mild cognitive impairment (MCI) who are at risk for AD, and (3) patients with moderate AD during active navigation, representing a cognitive task typically affected in AD. METHODS AND FINDINGS: Changes in regional cerebral blood flow (rCBF) were assessed with PET imaging during an active navigation task in a 3D virtual-reality environment. The task was based on visual cues exclusively; no auditory cues were provided. Age-matched groups of healthy individuals, patients with MCI, and patients with AD were examined. Specific differences in the activation patterns were observed in the three groups, with stronger activation of cerebellar portions and visual association cortex in controls and stronger activation of primary visual and frontal cortical areas in patients with MCI and AD. Highly significant bilateral decrease of rCBF in task-irrelevant auditory cortical regions was detected in healthy individuals during performance of the task. This rCBF decrease was interpreted as a cross-modal inhibitory effect. It was diminished in patients with MCI and completely absent in patients with AD. A regression analysis across all individuals revealed a clear positive relation between cognitive status (mini mental state examination score) and the extent of auditory cortical deactivation. CONCLUSION: During active navigation, a high level of movement automation and an involvement of higher-order cerebral association functions were observed in healthy controls. Conversely, in patients with MCI and AD, increased cognitive effort and attention towards movement planning, as well as stronger involvement of lower-order cerebral systems, was found. Successful cognitive performance in healthy individuals is associated with deactivation of task-irrelevant cerebral regions, whereas the development of AD appears to be characterized by a progressive impairment of cross-modal cerebral deactivation functions. These changes may cause the generally decreased ability of patients with AD to direct attention primarily to the relevant cognitive modality.
format Text
id pubmed-1216331
institution National Center for Biotechnology Information
language English
publishDate 2005
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-12163312005-09-20 Impaired Cross-Modal Inhibition in Alzheimer Disease Drzezga, Alexander Grimmer, Timo Peller, Martin Wermke, Marc Siebner, Hartwig Rauschecker, Josef P Schwaiger, Markus Kurz, Alexander PLoS Med Research Article BACKGROUND: Successful cognitive performance depends not only on the activation of specific neuronal networks but also on selective suppression of task-irrelevant modalities, i.e., deactivation of non-required cerebral regions. This ability to suppress the activation of specific brain regions has, to our knowledge, never been systematically evaluated in patients with Alzheimer disease (AD). The aim of the current study was to evaluate both cerebral activation and deactivation in (1) healthy volunteers, (2) patients with mild cognitive impairment (MCI) who are at risk for AD, and (3) patients with moderate AD during active navigation, representing a cognitive task typically affected in AD. METHODS AND FINDINGS: Changes in regional cerebral blood flow (rCBF) were assessed with PET imaging during an active navigation task in a 3D virtual-reality environment. The task was based on visual cues exclusively; no auditory cues were provided. Age-matched groups of healthy individuals, patients with MCI, and patients with AD were examined. Specific differences in the activation patterns were observed in the three groups, with stronger activation of cerebellar portions and visual association cortex in controls and stronger activation of primary visual and frontal cortical areas in patients with MCI and AD. Highly significant bilateral decrease of rCBF in task-irrelevant auditory cortical regions was detected in healthy individuals during performance of the task. This rCBF decrease was interpreted as a cross-modal inhibitory effect. It was diminished in patients with MCI and completely absent in patients with AD. A regression analysis across all individuals revealed a clear positive relation between cognitive status (mini mental state examination score) and the extent of auditory cortical deactivation. CONCLUSION: During active navigation, a high level of movement automation and an involvement of higher-order cerebral association functions were observed in healthy controls. Conversely, in patients with MCI and AD, increased cognitive effort and attention towards movement planning, as well as stronger involvement of lower-order cerebral systems, was found. Successful cognitive performance in healthy individuals is associated with deactivation of task-irrelevant cerebral regions, whereas the development of AD appears to be characterized by a progressive impairment of cross-modal cerebral deactivation functions. These changes may cause the generally decreased ability of patients with AD to direct attention primarily to the relevant cognitive modality. Public Library of Science 2005-10 2005-09-20 /pmc/articles/PMC1216331/ /pubmed/16159306 http://dx.doi.org/10.1371/journal.pmed.0020288 Text en Copyright: © 2005 Drzezga et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Drzezga, Alexander
Grimmer, Timo
Peller, Martin
Wermke, Marc
Siebner, Hartwig
Rauschecker, Josef P
Schwaiger, Markus
Kurz, Alexander
Impaired Cross-Modal Inhibition in Alzheimer Disease
title Impaired Cross-Modal Inhibition in Alzheimer Disease
title_full Impaired Cross-Modal Inhibition in Alzheimer Disease
title_fullStr Impaired Cross-Modal Inhibition in Alzheimer Disease
title_full_unstemmed Impaired Cross-Modal Inhibition in Alzheimer Disease
title_short Impaired Cross-Modal Inhibition in Alzheimer Disease
title_sort impaired cross-modal inhibition in alzheimer disease
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1216331/
https://www.ncbi.nlm.nih.gov/pubmed/16159306
http://dx.doi.org/10.1371/journal.pmed.0020288
work_keys_str_mv AT drzezgaalexander impairedcrossmodalinhibitioninalzheimerdisease
AT grimmertimo impairedcrossmodalinhibitioninalzheimerdisease
AT pellermartin impairedcrossmodalinhibitioninalzheimerdisease
AT wermkemarc impairedcrossmodalinhibitioninalzheimerdisease
AT siebnerhartwig impairedcrossmodalinhibitioninalzheimerdisease
AT rauscheckerjosefp impairedcrossmodalinhibitioninalzheimerdisease
AT schwaigermarkus impairedcrossmodalinhibitioninalzheimerdisease
AT kurzalexander impairedcrossmodalinhibitioninalzheimerdisease